PYRAZINAMIDE
PULMONARY TUBERCULOSIS·+2
QUALITEST/PAR P
Indication
Active tuberculosis
Active tuberculosis refers to a symptomatic, transmissible infectious disease caused by *Mycobacterium tuberculosis* when the host immune response fails to contain bacterial replication. Read more about Active tuberculosis
67 drugs 45 manufacturers
Drugs that treat it
Common Active tuberculosis therapies.
ISONIAZID
ISONIAZIDS·PULMONARY TUBERCULOSIS·+4
TEVA USA
CYCLOSERINE
CYCLOSERINES·PULMONARY TUBERCULOSIS·+3
MACLEODS PHARMA
PYRAZINAMIDE
PULMONARY TUBERCULOSIS·+2
Major Pharamceuticals
ISONIAZID
ISONIAZIDS·PULMONARY TUBERCULOSIS·+4
GSK Consumer Healthcare
PYRAZINAMIDE
PYRAZINAMIDE·PULMONARY TUBERCULOSIS·+2
GSK Consumer Healthcare
PYRAZINAMIDE
PYRAZINAMIDE·PULMONARY TUBERCULOSIS·+2
MACLEODS PHARMA
ETHAMBUTOL HCL
ETHAMBUTOL·PULMONARY TUBERCULOSIS·+1
EPIC PHARMA LLC
RIFAMPIN
RIFAMYCINS·ACTIVE TUBERCULOSIS·+3
EPIC PHARMA LLC
Filter & compare in the drug finder →Opens the drug finder with Active tuberculosis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonActive tuberculosis refers to a symptomatic, transmissible infectious disease caused by *Mycobacterium tuberculosis* when the host immune response fails to contain bacterial replication.
While it predominantly affects the pulmonary system, it can disseminate to extrapulmonary sites including the lymph nodes, central nervous system, kidneys, and musculoskeletal system.
Pathophysiologically, active disease is characterized by uncontrolled mycobacterial proliferation, granulomatous inflammation, and tissue necrosis.
Clinically, active tuberculosis manifests with constitutional features such as fever, night sweats, fatigue, and weight loss, frequently accompanied by localized signs such as chronic productive cough, hemoptysis, and chest pain in pulmonary disease.
- cdc.gov
Active tuberculosis refers to a symptomatic, transmissible infectious disease caused by *Mycobacterium tuberculosis* when the host immune response fails to contain bacterial replication While it predominantly affects the pulmonary system, it can disseminate to extrapulmonary sites including the lymph nodes, central nervous system, kidneys, and musculoskeletal system Clinically, active tuberculosis manifests with constitutional features such as fever, night sweats, fatigue, and weight loss, frequ...
- nih.gov
Active tuberculosis refers to a symptomatic, transmissible infectious disease caused by *Mycobacterium tuberculosis* when the host immune response fails to contain bacterial replication
- cdc.gov
Active tuberculosis refers to a symptomatic, transmissible infectious disease caused by *Mycobacterium tuberculosis* when the host immune response fails to contain bacterial replication While it predominantly affects the pulmonary system, it can disseminate to extrapulmonary sites including the lymph nodes, central nervous system, kidneys, and musculoskeletal system Pathophysiologically, active disease is characterized by uncontrolled mycobacterial proliferation, granulomatous inflammation, and ...
- cdc.gov
Pathophysiologically, active disease is characterized by uncontrolled mycobacterial proliferation, granulomatous inflammation, and tissue necrosis Clinically, active tuberculosis manifests with constitutional features such as fever, night sweats, fatigue, and weight loss, frequently accompanied by localized signs such as chronic productive cough, hemoptysis, and chest pain in pulmonary disease
Personalize your experience
Follow Active tuberculosis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.